Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

Clinical trial NCT00421954 · COMPLETED

Trial details

NCT number: NCT00421954
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophreniform Disorder Schizoaffective Disorder Psychosis Depressive Disorder, Major Bipolar Disorder

Start date: 2006-05-01
Primary completion: 2008-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.